Fertility company Spermosens' clinical validation study of JUNO-Checked Generation 3 at RMC in Malmö has started and is proceeding as planned. So far, seven patients have been tested successfully. The study includes IVF couples with unexplained infertility and normal sperm parameters, and is intended to confirm that the system can identify causes of failed fertilization. The study is expected to be completed before the end of the year.